[Federal Register Volume 60, Number 140 (Friday, July 21, 1995)]
[Notices]
[Pages 37644-37646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-18026]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[CDC-567]


Cooperative Agreement with the World Health Organization (WHO)

Summary

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of funds for fiscal year (FY) 1995 for a cooperative 
agreement with the World Health Organization (WHO) for initiatives 
related to emerging infectious diseases. Approximately $100,000 is 
available in FY 1995 to fund this program. It is expected that the 
award will begin on or about September 1, 1995, for a 12-month budget 
period within a project period of up to three years. Funding estimates 
may vary and are subject to change. Continuation awards within the 
project period will be made on the basis of satisfactory progress and 
availability of funds.
    The Public Health Service (PHS) is committed to achieving the 
health promotion and disease prevention objectives of ``Healthy People 
2000'', a PHS-led national activity to reduce morbidity and mortality 
and to improve the quality of life. This announcement focuses on the 
priority area of Immunization and Infectious Diseases. (For ordering a 
copy of ``Healthy People 2000'', see the section ``Where to Obtain 
Additional Information.'')

[[Page 37645]]


Authority

    This program is authorized under Sections 301 and 307 of the Public 
Health Service Act, 42 U.S.C. 241 and 242l, as amended.

Smoke-Free Workplace

    PHS strongly encourages all grant recipients to provide a smoke-
free workplace and to promote the non-use of all tobacco products, and 
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in 
certain facilities that receive Federal funds in which education, 
library, day care, health care, and early childhood development 
services are provided to children.

Eligible Applicant

    Assistance will be provided only to WHO for this project. No other 
applications are solicited. The program announcement and application 
kit have been sent to WHO.
    WHO is the only international/intergovernmental agency qualified to 
conduct the activities under this cooperative agreement because it has:
    A. A unique position among the world's health agencies as the 
technical agency for health within the United Nations.
    B. Access to all national health promotion and disease prevention 
programs and potential research sites through its six regional offices 
located in Washington, DC; Copenhagen, Denmark; Alexandria, Egypt; 
Brazzaville, Congo; Delhi, India; and Manila, Philippines.
    C. In collaboration with other international organizations, WHO 
works to accomplish its mission by disseminating information related to 
infectious disease program needs and services, recommends and advocates 
improved policies and programs, and provides consultation and guidance 
at the international, national, and local level.
    D. WHO offers special opportunities for furthering research 
programs through the use of unusual talent resources, populations, or 
environmental conditions in other countries that are not readily 
available in the United States or that provide augmentation of existing 
U.S. resources.
    E. WHO is uniquely qualified to conduct activities that have 
specific relevance to the mission and objectives of CDC and the 
potential to advance knowledge that would benefit the United States.

Purpose

    The purpose of this program is to assist WHO in implementing a 
coordinated plan to assist national governments and regional 
authorities to improve infectious disease surveillance, build public 
health infrastructure, promote applied research activities, and develop 
improved infectious disease prevention and control strategies. These 
efforts will lead to a better understanding of baseline infectious 
disease incidence and prevalence, so that ``unusual'' disease 
occurrences will be more readily recognized and accurately addressed. 
As infectious diseases do not respect international boundaries, 
outbreaks virtually anywhere may threaten the health of the United 
States, and the improved surveillance activities will offer national, 
international, and global early warning of new and unusual diseases so 
that effective interventions can be promptly instituted.

Program Requirements

    In carrying out the activities under this program, WHO will be 
responsible for the activities under A., below, and CDC will be 
responsible for the activities under B., below:

A. Recipient Activities

    1. Identify geographic areas, on a global basis, for implementation 
and evaluation of infectious disease surveillance activities.
    2. Develop and evaluate strategies to enhance national, regional, 
and global infectious disease surveillance.
    3. Analyze national resources devoted to infectious disease 
diagnosis to identify critical shortfalls in human, technical, and 
equipment resources, then develop and implement plans to resolve 
recognized deficiencies.
    4. Conduct a program of applied research focusing on recognition 
and response to emerging infectious diseases.
    5. Build international networks of collaborating laboratories for 
the rapid acquisition and exchange of surveillance and monitoring 
information.
    6. Coordinate activities with other relevant agencies, 
organizations, and individuals to facilitate development, 
implementation, and evaluation of infectious disease prevention and 
control programs.
    7. Monitor and evaluate program performance.

B. CDC Activities

    1. Collaborate in the design of research protocols.
    2. Assist in the analysis and interpretation of data generated from 
each project.
    3. As needed, provide other programmatic consultation and guidance 
in support of the program.
    4. Provide continuing updates on scientific and operational 
developments in emerging infectious diseases.
    5. Participate in the development of plans for the sharing and 
dissemination of program and research data and information.
    6. Assist in defining the scope, the development, and dissemination 
of plans for emerging infectious disease prevention, research, and 
control.

Evaluation Criteria

    The application will be reviewed and evaluated according to the 
following criteria:
    A. Needs Statement: The extent to which the applicant identifies 
specific needs related to the purposes of the program. (20 Points)
    B. Objectives: The degree to which short-term and long-term 
objectives are specific, time-phased, measurable, and realistic. (20 
Points)
    C. Operational Plan: The adequacy of the applicant's plan to carry 
out the proposed activities. (20 Points)
    D. Evaluation Plan: The extent to which the evaluation plan appears 
capable of monitoring progress toward meeting project objectives. (20 
Points)
    E. Program Management: The extent to which proposed staff are 
necessary, appropriate, and qualified to perform the proposed 
activities. (20 Points)
    F. Budget: The extent to which the budget is reasonable and 
consistent with the purpose and objectives of the program. (Not 
Weighted)

Executive Order 12372 Review

    This application is not subject to review under Executive Order 
12372, Intergovernmental Review of Federal Programs.

Public Health System Reporting Requirements

    This program is not subject to the Public Health System Reporting 
Requirements.

Catalog of Federal Domestic Assistance Number

    The Catalog of Federal Domestic Assistance Number for this program 
is 93.283.

Other Requirements

Paperwork Reduction Act

    Projects that involve the collection of information from 10 or more 
individuals and funded by the cooperative agreement will be subject to 
review by the Office of Management and Budget

[[Page 37646]]
(OMB) under the Paperwork Reduction Act.

Human Subjects

    If the proposed project involves research on human subjects, the 
applicant must comply with the Department of Health and Human Services 
Regulations (45 CFR Part 46) regarding the protection of human 
subjects. Assurance must be provided to demonstrate that the project 
will be subject to initial and continuing review by an appropriate 
institutional review committee. The applicant will be responsible for 
providing assurance in accordance with the appropriate guidelines and 
form provided in the application kit.

Application Submission and Deadline

    The WHO must submit an original and two copies of the application 
Form PHS-5161-1 (Revised 7/92, OMB Number 0937-0189) to Clara M. 
Jenkins, Grants Management Officer, Grants Management Branch, 
Procurement and Grants Office, Centers for Disease Control and 
Prevention (CDC), 255 East Paces Ferry Road, NE., Room 314, Mailstop E-
18, Atlanta, Georgia 30305, on or before August 21, 1995.

Where To Obtain Additional Information

    If you are interested in obtaining additional information on this 
program, please refer to Announcement Number 567 and contact Gordon R. 
Clapp, Grants Management Specialist, Grants Management Branch, 
Procurement and Grants Office, Centers for Disease Control and 
Prevention (CDC), 255 East Paces Ferry Road, NE., Room 314, Mailstop E-
18, Atlanta, Georgia 30305, telephone (404) 842-6508.
    Programmatic technical assistance may be obtained from Pat 
McConnon, National Center for Infectious Diseases, Centers for Disease 
Control and Prevention (CDC), Mailstop C-12, 1600 Clifton Road, NE., 
Atlanta, Georgia 30333, telephone (404) 639-2175, Email address: 
[email protected].
    Please refer to Announcement Number 567 when requesting information 
regarding this program.
    WHO may obtain a copy of Healthy People 2000 (Full Report, Stock 
No. 017-001-00474-0) or Healthy People 2000 (Summary Report, Stock No. 
017-001-00473-1) referenced in the Summary through the Superintendent 
of Documents, Government Printing Office, Washington, DC 20402-9325, 
telephone (202) 512-1800.

    Dated: July 17, 1995.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 95-18026 Filed 7-20-95; 8:45 am]
BILLING CODE 4163-18-P